ResMed: Waiting For The Next Catalyst, Initiating With Hold Rating [Seeking Alpha]
ResMed Inc. (RMD)
Last resmed inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.resmed.com/investor-relations/default.aspx
Company Research
Source: Seeking Alpha
RMD's recurring revenue model leverages device sales, consumables, and SaaS, with growth driven by rising diagnosis and treatment rates. Market concerns over GLP-1s and Apnimed's AD109 may pressure RMD until AD109's likely 2026–2027 launch clarifies competitive impact. RMD trades at 22x forward P/E versus a 30x historical average, implying 30% upside if valuation normalizes and sales growth persists. Asia-Pacific Images Studio/iStock via Getty Images Investment thesis We initiate coverage of ResMed ( RMD ) with a hold rating, although I am bullish long-term on the company's dominant global positioning on the obstructive sleep apnea space, which has multiple tail winds This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation
Show less
Read more
Impact Snapshot
Event Time:
RMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RMD alerts
High impacting ResMed Inc. news events
Weekly update
A roundup of the hottest topics
RMD
News
- ResMed (RMD) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "buy (b-)" to "hold (c+)".MarketBeat
- After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD) [Yahoo! Finance]Yahoo! Finance
- Is It Time To Reconsider ResMed (RMD) After The Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- Is ResMed Stock Underperforming the Nasdaq? [Yahoo! Finance]Yahoo! Finance
- ResMed (RMD) Stock Trades Down, Here Is Why [Yahoo! Finance]Yahoo! Finance
RMD
Earnings
- 1/29/26 - Beat
RMD
Sec Filings
- 3/11/26 - Form 4
- 3/9/26 - Form 144
- 3/5/26 - Form 4
- RMD's page on the SEC website